Description du projet
Personal Health Systems for Monitoring and Point-of-Care diagnostics
TheraEDGE is an industry-driven effort to accelerate the adoption of theranostics applications in Primary Care by pushing Point of Care Test (POCT) technology far beyond its current state-of-the-art and by delivering clinical, analytical and operational breakthroughs.TheraEDGE is built around the high-incidence clinical case of early-diagnosing lower respiratory tract infections in Primary Care. Simultaneous testing for different pathogens and their antibiotic resistance will have a huge European impact:better clinical outcomes and standards of care through more effective and timely diagnosis and treatmentimproved health economics through optimization of antibiotics prescription, infection control practices and reduction of clinical visits or hospital stayssubstantial business for the In Vitro Diagnostics industry through the standardisation and commercialization of innovative POCT products and systemsTheraEDGE consists of three multidisciplinary platforms:a core Lab-On-a-Chip supporting multi-marker assays and using Single Molecule Detection (SMD) as an alternative to PCR-based molecular diagnostics. SMD removes the need for amplification and has the potential to become a key enabler for Nucleic Acid Testing at the Point of Care by providing less complex, faster, more sensitive and more specific assaysan architecture that provides Plug and Play semantic interoperability and creates opportunities for the standardisation of POCT instruments and information systems, offering radical usability, robustness and vendor interoperability improvements. Practitioners will be able to run out-of-the-box multiple compliant devices from one single PDA-based operator interfacea set of applications built on a convergent ITC platform that supports General Practitioners in their patient management and clinical decision-making, and provides therapeutic services for patient education and compliance monitoring in order to fight antibiotic misuse and abuse.
Champ scientifique
- natural sciencesbiological sciencesbiochemistrybiomoleculesnucleic acids
- engineering and technologyother engineering and technologiesmicrotechnologylab on a chip
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibiotics
- social scienceseconomics and businesseconomicshealth economics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Appel à propositions
FP7-ICT-2007-1
Voir d’autres projets de cet appel
Régime de financement
CP - Collaborative project (generic)Coordinateur
08186 LLIÇA D´AMUNT
Espagne
Voir sur la carte
Participants (15)
2000 Antwerpen
Voir sur la carte
33615 Bielefeld
Voir sur la carte
01069 Dresden
Voir sur la carte
55129 Mainz
Voir sur la carte
08036 BARCELONA
Voir sur la carte
08007 Barcelona
Voir sur la carte
08186 LLICA D'AMUNT
Voir sur la carte
08186 LLICA D´AMUNT
Voir sur la carte
10123 TORINO
Voir sur la carte
7522 NB Enschede
Voir sur la carte
2500-750 Caldas Da Rainha
Voir sur la carte
581 83 Linköping
Voir sur la carte
81339 BRATISLAVA
Voir sur la carte
CB2 1TN Cambridge
Voir sur la carte
TF9 4PA Shropshire
Voir sur la carte